NANO MRNA Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3651120002
JPY
100.00
1 (1.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Morishita Jintan Co., Ltd.
Pharma Foods International Co., Ltd.
Kissei Pharmaceutical Co., Ltd.
CB GROUP MANAGEMENT Co., Ltd.
Astena Holdings Co., Ltd.
O'will Corp.
Yomeishu Seizo Co., Ltd.
euglena Co., Ltd.
NANO MRNA Co., Ltd.
CellSeed, Inc.
Ohki Health Care Holdings, Inc.

Why is NANO MRNA Co., Ltd. ?

1
Poor Management Efficiency with a low ROE of 0%
  • The company has reported losses. Due to this company has reported negative ROE
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1,100.28
  • Poor long term growth as Net Sales has grown by an annual rate of -15.68% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1,100.28
  • The company has reported losses. Due to this company has reported negative ROE
3
Poor long term growth as Net Sales has grown by an annual rate of -15.68% over the last 5 years
4
Flat results in Jun 26
  • INTEREST(9M) At JPY 18.43 MM has Grown at inf%
  • NET SALES(Q) At JPY 35.7 MM has Fallen at -18.17%
  • ROCE(HY) Lowest at -34.31%
5
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -31.25%, its profits have fallen by -70.4%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is NANO MRNA Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
NANO MRNA Co., Ltd.
-30.07%
-0.61
68.74%
Japan Nikkei 225
60.14%
2.04
29.37%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-15.68%
EBIT Growth (5y)
2.94%
EBIT to Interest (avg)
-957.89
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.08
Sales to Capital Employed (avg)
0.03
Tax Ratio
0.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.05
EV to EBIT
-6.17
EV to EBITDA
-6.17
EV to Capital Employed
-57.93
EV to Sales
34.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-31.21%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
NET SALES(HY)

At JPY 79.26 MM has Grown at 139.44%

NET PROFIT(HY)

Higher at JPY -558.02 MM

RAW MATERIAL COST(Y)

Fallen by -12.9% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 26.92 times

-16What is not working for the Company
INTEREST(9M)

At JPY 18.43 MM has Grown at inf%

NET SALES(Q)

At JPY 35.7 MM has Fallen at -18.17%

ROCE(HY)

Lowest at -34.31%

DEBT-EQUITY RATIO (HY)

Highest at -91.1 %

PRE-TAX PROFIT(Q)

At JPY -273.76 MM has Fallen at -26.31%

NET PROFIT(Q)

Lowest at JPY -281.15 MM

Here's what is working for NANO MRNA Co., Ltd.

Debtors Turnover Ratio
Highest at 26.92 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -12.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for NANO MRNA Co., Ltd.

Interest
At JPY 18.43 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Sales
At JPY 35.7 MM has Fallen at -18.17%
over average net sales of the previous four periods of JPY 43.62 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (JPY MM)

Pre-Tax Profit
At JPY -273.76 MM has Fallen at -26.31%
over average net sales of the previous four periods of JPY -216.73 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit
Lowest at JPY -281.15 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

Net Profit
At JPY -281.15 MM has Fallen at -29.26%
over average net sales of the previous four periods of JPY -217.52 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

Debt-Equity Ratio
Highest at -91.1 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio